The authors wish to make a correction to the published version of their paper \[[@B1-nutrients-11-00680]\]. While replying to a Letter to the Editor \[[@B2-nutrients-11-00680]\], we re-examined our results and realized that an erroneous version of [Table 4](#nutrients-11-00680-t004){ref-type="table"} had been accidentally incorporated into the paper. During the manuscript review process, we were asked to reorder the table columns, include the standard deviations, and include all of the *p* values. Due to the substantial nature of these edits, many errors were accidentally introduced into this table. We sincerely apologize for this unfortunate error and regret any subsequent confusion. A corrected version of [Table 4](#nutrients-11-00680-t004){ref-type="table"} is below.

This change does not impact the overall results or scientific conclusions. The original manuscript will remain online on the article webpage, with a reference to this correction.

nutrients-11-00680-t004_Table 4

###### 

Fatty acid profile (g/100 g of fatty acids) of total plasma phospholipids in preterm infants, receiving human milk fortified with a control (cHMF) or with a new human milk fortifier (nHMF) before and after 21 days of treatment. Estimates of the treatment effect nHMF/cHMF (difference) and the two-sided *p*-values are given for each fatty acid analyzed in the different lipid compartments.

                           cHMF (*n* = 21)   nHMF (*n* = 26)                                                         
  ------------------------ ----------------- ----------------- ------- ------ ------- ------ ------- ------ -------- -------
  14:0                     0.21              0.14              0.22    0.14   0.24    0.13   0.26    0.13   0.184    0.500
  15:0                     0.13              0.10              0.18    0.26   0.14    0.08   0.12    0.03   −0.071   0.722
  16:0                     25.00             5.55              22.75   6.21   26.00   3.58   26.46   2.76   0.180    0.020
  16:0 DMA                 0.63              0.18              0.70    0.17   0.64    0.16   0.74    0.27   −0.134   0.394
  16:1 *n*-7               1.24              0.71              1.05    1.19   1.28    0.69   0.93    0.70   0.209    0.188
  16:1 *n*-9               0.32              0.14              0.24    0.15   0.30    0.12   0.25    0.13   0.219    0.117
  18:0                     14.99             2.90              17.25   4.15   14.51   1.65   15.84   1.63   −0.060   0.203
  18:0 DMA                 0.33              0.12              0.47    0.37   0.35    0.10   0.36    0.14   −0.402   0.040
  18:1 DMA                 0.29              0.14              0.32    0.11   0.30    0.09   0.30    0.13   −0.288   0.054
  18:1 *n*-7               3.07              0.59              2.36    0.62   3.05    0;89   2.59    0.77   0.122    0.015
  18:1 *n*-9               14.04             2.16              11.98   3.37   13.90   3.03   12.45   2.97   0.051    0.286
  *trans*-18:1             0.30              0.15              0.42    0.16   0.39    0.13   0.40    0.17   −0.112   0.515
  18:2 *n*-6 (LA)          12.90             3.20              14.60   2.53   14.03   2.75   14.69   2.55   0.043    0.452
  18:3 *n*-3 (ALA)         0.18              0.14              0.11    0.05   0.18    0.10   0.17    0.08   0.219    0.125
  18:3 *n*-6 (GLA)         0.22              0.07              0.17    0.06   0.22    0.06   0.16    0.04   0.030    0.689
  20:0                     0.36              0.29              0.40    0.31   0.38    0.21   0.41    0.18   0.011    0.945
  20:1 *n*-9               0.25              0.08              0.31    0.09   0.27    0.10   0.36    0.12   0.156    0.072
  20:2 *n*-6               0.47              0.13              0.67    0.46   0.51    0.11   0.53    0.10   −0.112   0.340
  20:3 *n*-6 (DGLA)        3.79              0.89              4.04    1.05   3.46    0.72   3.45    0.68   −0.161   0.041
  20:3 *n*-9               2.56              1.46              1.90    1.53   2.12    1.19   2.11    1.51   0.089    0.612
  20:4 *n*-6 (ARA)         9.81              2.33              10.63   3.54   9.09    2.03   8.26    2.58   −0.211   0.015
  20:5 *n*-3 (EPA)         0.84              0.48              0.70    0.25   0.88    0.32   0.97    0.28   0.318    0.006
  22:0                     0.46              0.39              0.53    0.53   0.53    0.33   0.57    0.27   0.110    0.567
  22:1 *n*-9               0.05              0.03              0.05    0.03   0.05    0.02   0.05    0.02   0.048    0.676
  22:4 *n*-6               0.46              0.17              0.49    0.29   0.40    0.13   0.35    0.10   −0.257   0.032
  22:5 *n*-3 (*n*-3 DPA)   0.46              0.24              0.53    0.31   0.44    0.12   0.40    0.12   −0.217   0.037
  22:5 *n*-6 (*n*-6 DPA)   0.49              0.19              0.53    0.25   0.45    0.25   0.50    0.22   −0.005   0.970
  22:6 *n*-3 (DHA)         3.60              1.42              3.96    1.94   3.22    0.93   3.54    1.04   −0.050   0.575
  24:0                     0.39              0.29              0.53    0.80   0.48    0.28   0.43    0.18   −0.056   0.742
  24:1 *n*-9               1.50              1.23              1.47    0.83   1.55    0.98   1.77    0.73   0.191    0.368

Data are presented as geometric mean and geometric standard deviation (SD). ALA, α-linolenic acid; ARA, arachidonic acid; DGLA, dihomo-γ-linolenic acid; DHA, docosahexaenoic acid; DMA, dimethyl acetal; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; GLA, γ-linolenic acid; LA, linoleic acid.
